Impact of Esmya on Fertility to Infertile Women With Fibroids Managed With Assisted Reproduction Techniques (NACRE)
A Retrospective, National, Multicenter Study Evaluating the Impact of Ulipristal Acetate (Esmya®) on Infertility to Infertile Women With Fibroids Managed With Assisted Reproduction Techniques (ART)
Sponsor: ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITRO
Listed as NCT03349190, this observational or N/A phase trial focuses on Fibroid Uterus and Infertility, Female and remains completed. Sponsored by ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITRO, it has been updated 10 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Feb 2019 — Jan 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
▶ Show 5 earlier versions
-
Aug 2018 — Feb 2019 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting · Phase: NA → None
-
Dec 2017 — Apr 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITRO
- Gedeon Richter Plc.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Angers, France , Besançon, France , Bordeaux, France , Bruges, France , Créteil, France , Dijon, France , Lille, France , Marseille, France , Montpellier, France , Nice, France and 7 more locations